Cargando…
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
BACKGROUND: The survival rate of patients with advanced high-grade serous ovarian carcinoma (HGSOC) remains disappointing. Clinically translatable orthotopic cell line xenograft models and patient-derived xenografts (PDXs) may aid the implementation of more personalised treatment approaches. Althoug...
Autores principales: | Kleinmanns, Katrin, Bischof, Katharina, Anandan, Shamundeeswari, Popa, Mihaela, Akslen, Lars A., Fosse, Vibeke, Karlsen, Ida Tveit, Gjertsen, Bjørn T., Bjørge, Line, McCormack, Emmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248428/ https://www.ncbi.nlm.nih.gov/pubmed/32454401 http://dx.doi.org/10.1016/j.ebiom.2020.102782 |
Ejemplares similares
-
The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer
por: Helland, Øystein, et al.
Publicado: (2016) -
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study
por: Thomsen, Liv Cecilie Vestrheim, et al.
Publicado: (2023) -
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods
por: Anandan, Shamundeeswari, et al.
Publicado: (2021)